Literature DB >> 7637716

Characterization of the lipid moiety of the glycosylphosphatidylinositol anchor of Trypanosoma cruzi 1G7-antigen.

N Heise1, M L de Almeida, M A Ferguson.   

Abstract

The 90-kDa stage-specific 1G7-antigen has been implicated in the invasion of host cells by the metacyclic forms of Trypanosoma cruzi. The antigen is attached to the plasma membrane via glycosylphosphatidylinositol, the partial structure of which was the first to be determined for a protein of this parasite. In this study, the complete structure of the lipid component of the anchor was determined by electrospray mass spectrometry, gas chromatography mass spectrometry, phospholipase sensitivity and high-performance thin-layer chromatography of the diaradylglycerol components after benzoylation. These analyses showed that the lipid moiety of 1G7-antigen is composed essentially of 1-O-hexadecyl-2-O-hexadecanoyl-phosphatidylinositol and 1-O-hexadecyl-2-O-octadecanoyl-phosphatidylinositol. The high sensitivity of the electrospray mass spectrometric analysis unexpectedly revealed the presence of a small proportion of putative inositol-phosphoceramide structures, and confirmed the absence of inositol-acylated species. An interesting finding was that the biosynthetic incorporation of [3H]palmitate labelled solely the acyl position, and not the 1-O-alkyl chain in the 1G7-antigen anchor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7637716     DOI: 10.1016/0166-6851(95)00009-p

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  12 in total

1.  Lipase-catalyzed monoesterification of 1-O-hexadecylglycerol in organic solvents.

Authors:  L E Bertello; M L Salto; R M de Lederkremer
Journal:  Lipids       Date:  1997-08       Impact factor: 1.880

2.  Infectivity of Trypanosoma cruzi strains is associated with differential expression of surface glycoproteins with differential Ca2+ signalling activity.

Authors:  R C Ruiz; S Favoreto; M L Dorta; M E Oshiro; A T Ferreira; P M Manque; N Yoshida
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

Review 3.  Sphingolipids in parasitic protozoa.

Authors:  Kai Zhang; James D Bangs; Stephen M Beverley
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 4.  The surface glycoconjugates of trypanosomatid parasites.

Authors:  M A Ferguson
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

5.  Characterization of the inositol phosphorylceramide synthase activity from Trypanosoma cruzi.

Authors:  Juliana M Figueiredo; Wagner B Dias; Lucia Mendonça-Previato; José O Previato; Norton Heise
Journal:  Biochem J       Date:  2005-04-15       Impact factor: 3.857

6.  Molecular and functional characterization of the ceramide synthase from Trypanosoma cruzi.

Authors:  Juliana M Figueiredo; Deivid C Rodrigues; Rafael C M C Silva; Carolina M Koeller; James C Jiang; S Michal Jazwinski; José O Previato; Lucia Mendonça-Previato; Turán P Urményi; Norton Heise
Journal:  Mol Biochem Parasitol       Date:  2011-12-30       Impact factor: 1.759

7.  Evidence for phospholipases from Trypanosoma cruzi active on phosphatidylinositol and inositolphosphoceramide.

Authors:  L E Bertello; M J Alves; W Colli; R M de Lederkremer
Journal:  Biochem J       Date:  2000-01-01       Impact factor: 3.857

Review 8.  Secretory pathway of trypanosomatid parasites.

Authors:  Malcolm J McConville; Kylie A Mullin; Steven C Ilgoutz; Rohan D Teasdale
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

9.  Structural analysis of inositol phospholipids from Trypanosoma cruzi epimastigote forms.

Authors:  L E Bertello; M F Gonçalvez; W Colli; R M de Lederkremer
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

10.  Genes for glycosylphosphatidylinositol toxin biosynthesis in Plasmodium falciparum.

Authors:  Mauro Delorenzi; Adrienne Sexton; Hosam Shams-Eldin; Ralph T Schwarz; Terry Speed; Louis Schofield
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.